Miller Howard Investments Inc. NY lifted its holdings in stocks of Johnson & Johnson (NYSE:JNJ – Loose Record) via 0.3% within the 2d quarter, HoldingsChannel experiences. The institutional investor owned 488,004 stocks of the corporate’s inventory after purchasing an extra 1,333 stocks all the way through the length. Johnson & Johnson accounts for roughly 2.9% of Miller Howard Investments Inc. NY’s holdings, making the inventory its 2d biggest retaining. Miller Howard Investments Inc. NY’s holdings in Johnson & Johnson have been price $80,774,000 as of its most up-to-date submitting with the Securities and Alternate Fee (SEC).

Different hedge finances have additionally lately added to or lowered their stakes within the corporate. Atlantic Non-public Wealth LLC received a brand new place in Johnson & Johnson within the 1st quarter valued at $32,000. Ruedi Wealth Control Inc. received a brand new stake in stocks of Johnson & Johnson within the 4th quarter price $42,000. 25 LLC received a brand new stake in stocks of Johnson & Johnson within the 1st quarter price $55,000. Horizons Wealth Control larger its stake in stocks of Johnson & Johnson via 1,730.0% within the 2d quarter. Horizons Wealth Control now owns 366 stocks of the corporate’s inventory price $61,000 after obtaining an extra 346 stocks all the way through the ultimate quarter. In spite of everything, Bay Harbor Wealth Control LLC received a brand new stake in stocks of Johnson & Johnson within the 2d quarter price $66,000. 68.40% of the inventory is owned via institutional buyers and hedge finances.

Johnson & Johnson Value Efficiency

JNJ inventory opened at $158.35 on Wednesday. The corporate has a debt-to-equity ratio of 0.44, a present ratio of one.12 and a handy guide a rough ratio of 0.88. The company has a marketplace capitalization of $411.55 billion, a P/E ratio of 32.05, a P/E/G ratio of three.19 and a beta of 0.55. The trade’s 50-day transferring moderate is $163.91 and its two-hundred day transferring moderate is $162.50. Johnson & Johnson has a 1 yr low of $150.11 and a 1 yr top of $181.04.

Johnson & Johnson (NYSE:JNJ – Get Loose Record) ultimate posted its quarterly profits effects on Thursday, July twentieth. The corporate reported $2.80 profits according to proportion (EPS) for the quarter, beating analysts’ consensus estimates of $2.62 via $0.18. The corporate had income of $25.53 billion for the quarter, in comparison to analyst estimates of $24.63 billion. Johnson & Johnson had a go back on fairness of 36.72% and a web margin of 13.35%. Johnson & Johnson’s income for the quarter was once up 6.3% in comparison to the similar quarter ultimate yr. All through the similar quarter ultimate yr, the corporate earned $2.59 EPS. Analysts look forward to that Johnson & Johnson will publish 10.02 profits according to proportion for the present fiscal yr.

Johnson & Johnson Dividend Announcement

The company additionally lately declared a quarterly dividend, which was once paid on Thursday, September seventh. Traders of document on Monday, August twenty eighth have been paid a $1.19 dividend. The ex-dividend date was once Friday, August twenty fifth. This represents a $4.76 dividend on an annualized foundation and a dividend yield of three.01%. Johnson & Johnson’s dividend payout ratio (DPR) is right now 96.36%.

Analyst Upgrades and Downgrades

Quite a lot of analysts have issued experiences at the corporate. Raymond James lower their goal value on Johnson & Johnson from $184.00 to $179.00 and set an “outperform” ranking for the corporate in a analysis word on Tuesday, September fifth. Cantor Fitzgerald reaffirmed an “obese” ranking and issued a $215.00 goal value on stocks of Johnson & Johnson in a analysis word on Monday. TheStreet upgraded Johnson & Johnson from a “c+” ranking to a “b+” ranking in a document on Monday, August twenty first. Barclays reduced their value goal on Johnson & Johnson from $175.00 to $158.00 and set an “equivalent weight” ranking for the corporate in a document on Friday, September eighth. In spite of everything, JPMorgan Chase & Co. larger their value goal on Johnson & Johnson from $175.00 to $180.00 and gave the inventory a “impartial” ranking in a document on Friday, July twenty first. 9 equities analysis analysts have rated the inventory with a hang ranking, six have given a purchase ranking and one has issued a powerful purchase ranking to the corporate’s inventory. Consistent with information from MarketBeat, Johnson & Johnson right now has a consensus ranking of “Reasonable Purchase” and a consensus goal value of $171.06.

View Our Newest Inventory Research on Johnson & Johnson

Insider Task at Johnson & Johnson

In comparable information, insider William Hait bought 14,698 stocks of Johnson & Johnson inventory in a transaction that happened on Wednesday, July twenty sixth. The inventory was once bought at a mean value of $172.00, for a complete price of $2,528,056.00. Following the sale, the insider now immediately owns 87,747 stocks within the corporate, valued at $15,092,484. The transaction was once disclosed in a record filed with the SEC, which can also be accessed thru this hyperlink. In comparable information, insider William Hait bought 14,698 stocks of Johnson & Johnson inventory in a transaction that happened on Wednesday, July twenty sixth. The inventory was once bought at a mean value of $172.00, for a complete price of $2,528,056.00. Following the sale, the insider now immediately owns 87,747 stocks within the corporate, valued at $15,092,484. The transaction was once disclosed in a record filed with the SEC, which can also be accessed thru this hyperlink. Additionally, VP Peter Fasolo bought 20,000 stocks of Johnson & Johnson inventory in a transaction that happened on Tuesday, July twenty fifth. The stocks have been bought at a mean value of $170.32, for a complete price of $3,406,400.00. Following the final touch of the sale, the vp now owns 102,696 stocks within the corporate, valued at $17,491,182.72. The disclosure for this sale can also be discovered right here. Corporate insiders personal 0.20% of the corporate’s inventory.

Johnson & Johnson Profile

(Loose Record)

Johnson & Johnson, along side its subsidiaries, researches, develops, manufactures, and sells quite a lot of merchandise within the healthcare box international. The corporate’s Client Well being phase supplies pores and skin well being/attractiveness merchandise underneath the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX manufacturers; child care merchandise underneath the JOHNSON’S and AVEENO Child manufacturers; oral care merchandise underneath the LISTERINE logo; TYLENOL acetaminophen merchandise; SUDAFED chilly, flu, and allergic reaction merchandise; BENADRYL and ZYRTEC allergic reaction merchandise; MOTRIN IB ibuprofen merchandise; NICORETTE smoking cessation merchandise; and PEPCID acid reflux disorder merchandise.

Learn Extra

Need to see what different hedge finances are retaining JNJ? Discuss with HoldingsChannel.com to get the most recent 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Loose Record).

Obtain Information & Rankings for Johnson & Johnson Day by day – Input your electronic mail deal with underneath to obtain a concise day-to-day abstract of the most recent information and analysts’ scores for Johnson & Johnson and comparable firms with MarketBeat.com’s FREE day-to-day electronic mail e-newsletter.